Ali Al-Mousawi

Ali Al-Mousawi is a Clinical Assistant Professor affiliated with the Grønbæk Group at the Biotech Research and Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research bridges hematology and dermatology, focusing on translational clinical studies in myeloid malignancies and inflammatory skin conditions.

His primary research interests include cytokine modulation in clonal cytopenia and low-risk myeloid malignancies, vitamin C supplementation therapy, and objective assessment of psoriasis severity through patient-taken photographs. This dual focus reflects an interdisciplinary approach to hematology-oncology and dermatological diagnostics, emphasizing patient-driven data collection and nutritional interventions in cancer contexts.

Analysis of his 2024 publications reveals strong emphasis on clinical trial methodology (EVI-2 Trial) and validation of telemedicine tools. The hematology work explores inflammatory biomarkers in pre-leukemic conditions, while the dermatology study critically evaluates discrepancies between patient self-assessment and physician evaluation in psoriasis management.

Dr. Al-Mousawi operates within the Grønbæk Group at BRIC, a translational research hub led by Professor Kirsten Grønbæk specializing in hematological malignancies like acute myeloid leukemia and myelodysplastic syndromes. The group leverages molecular biology and clinical data to develop targeted therapies, with recent work extending into nutritional oncology and digital health applications.